Cover image of the article: Recurrence and Survival Effect in Breast Conserving Surgery: What are the Predictive and/or Prognostic Factors?

Image Credit:Int J Cancer Manag

Recurrence and Survival Effect in Breast Conserving Surgery: What are the Predictive and/or Prognostic Factors?

Authors

ME Akbari1, M Mozaffar1, A Heidari1, H Zirakzadeh1, Atieh Akbari1,*, M Akbari1, F Hosseinizadegan Shirazi1
1Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*Corresponding Author: Corresponding author: Atieh Akbari, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Tel: +98-2122744090, E-mail: Email: drakbari.drakbari@gmail.com

International Journal of Cancer Management:Vol. 4, issue 2; e80729
Published online:Jun 30, 2011
Article type:Research Article
Received:Jan 09, 2011
Accepted:Mar 25, 2011
How to Cite:Akbari M, Mozaffar M, Heidari A, Zirakzadeh H, Akbari A, et al. Recurrence and Survival Effect in Breast Conserving Surgery: What are the Predictive and/or Prognostic Factors?. Int J Cancer Manag. 2011;4(2):e80729. doi:

Abstract

Background: Breast conserving surgery (BCS) is a widely accepted form of operation in patients with early breast cancer. Recurrence remains one of the greatest concerns in breast conserving surgery. It can provoke serious anxiety in the patient and, when treated by mastectomy, negate the objective of conservation.

Methods: In this study we investigated the prognostic value of demographic, clinical and pathological factors and biological markers in breast cancer patients treated with BCS. This study was performed on 258 patients who underwent BCS from 2002 to 2010. All of the surgeries were performed by a single surgical team. Recurrence and its risk factors were evaluated.

Results: The mean age of the patients at the time of diagnosis was 50. The overall 10 year survival was 81%, 5 year survival was 88% and recurrence rate after surgery was 9%. Lymphovascular Invasion (LVI) was observed in 41 (16%) patients and in 11 (48%) patients with recurrence.

Conclusion: Our study confirmed that tumors with estrogen receptor negative and LVI had more recurrence rate but other demographic, clinical and pathological factors and biological markers (progesterone receptor, P53, HER-2) did not have any significant effect on recurrence. We recommend considering LVI and estrogen receptor assay as a prognostic factor in the patients treated with BCS.

Highlights

Fulltext

The Full text is available in PDF.

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Apr
2008
Five and Ten Years Survival in Breast Cancer Patients Mastectomies vs. Breast Conserving Surgeries Personal Experience

Five and Ten Years Survival in Breast Cancer Patients Mastectomies vs. Breast Conserving Surgeries Personal Experience

ME Akbari,
M Khayamzadeh,
SJ Khoshnevis,
N Nafisi,
A Akbari

Akbari M, Khayamzadeh M, Khoshnevis S, Nafisi N, Akbari A. Five and Ten Years Survival in Breast Cancer Patients Mastectomies vs. Breast Conserving Surgeries Personal Experience. Int J Cancer Manag. 2008;1(2):e80407. doi:

3
Feb
2020
Outcomes of Breast Conservation Surgery and Modified Radical Mastectomy After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer

Outcomes of Breast Conservation Surgery and Modified Radical Mastectomy After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer

Mohammad Esmaeil Akbari,
Belal Delshad,
Mostafa Mousavizadeh

Akbari ME, Delshad B, Mousavizadeh M. Outcomes of Breast Conservation Surgery and Modified Radical Mastectomy After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer. Int J Cancer Manag. 2020;13(2):e14297. doi: https://doi.org/10.5812/ijcm.14297

10
Dec
2016
Prognostic Factors of Recurrence (Early and Late) and Death in Breast Cancer Patients in Iranian Women

Prognostic Factors of Recurrence (Early and Late) and Death in Breast Cancer Patients in Iranian Women

Mohammad Esmaeil Akbari,
Atieh Akbari,
Nahid Nafissi,
Zeinab Shormeij,
Soheila Sayad,
Marzieh Rohani Rasaf
,et al.

Akbari ME, Akbari A, Nafissi N, Shormeij Z, Sayad S, et al. Prognostic Factors of Recurrence (Early and Late) and Death in Breast Cancer Patients in Iranian Women. Int J Cancer Manag. 2016;9(6):e5747. doi: https://doi.org/10.17795/ijcp-5747

30
Dec
2011
Margin Status Influence on the Outcome of Patients Treated with Breast Conserving Surgery

Margin Status Influence on the Outcome of Patients Treated with Breast Conserving Surgery

ME Akbari,
Masoud Akbari,
H Zirakzadeh,
N Nafisi,
A Heidari,
F Hosseinizadegan Shirazi

Akbari M, Akbari M, Zirakzadeh H, Nafisi N, Heidari A, et al. Margin Status Influence on the Outcome of Patients Treated with Breast Conserving Surgery. Int J Cancer Manag. 2011;4(4):e80784. doi:

14
Dec
2019
A Comparative Matched Study of Breast-Conserving Therapy and Modified Radical Mastectomy in Iranian Women

A Comparative Matched Study of Breast-Conserving Therapy and Modified Radical Mastectomy in Iranian Women

Mohammad Houshyari,
Afshin Rakhsha,
Mohammadreza Khademi,
Amir Shahram Yousefi Kashi

Houshyari M, Rakhsha A, Khademi M, Yousefi Kashi AS. A Comparative Matched Study of Breast-Conserving Therapy and Modified Radical Mastectomy in Iranian Women. Int J Cancer Manag. 2019;13(4):e92798. doi: https://doi.org/10.5812/ijcm.92798

More by these authors

ME AkbariPubMedScholar
M MozaffarPubMedScholar
A HeidariPubMedScholar
H ZirakzadehPubMedScholar
Atieh AkbariPubMedScholar
F Hosseinizadegan ShiraziPubMedScholar
Share
Cited by
Metrics